Radhakrishnan J, Remuzzi G, Saran R, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. pdf icon[PDF – 283K]external icon Kidney Int. 2014;86(2):246-250.

Grams ME, Plantinga LC, Hedgeman E, et al. Validation of CKD and related conditions in existing data sets: a systematic review. pdf icon[PDF – 363K]external icon Am J Kidney Dis. 2011;57(1):44–54.

Grams ME, Plantinga LC, Hedgeman E, et al. Establishing a national chronic kidney disease surveillance system for the United States. pdf icon[PDF – 110K]external icon Clin J Am Soc Nephrol. 2010;5(1):152−161.

Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges pdf icon[PDF-357K]external icon Am J Kidney Dis. 2009;53(3 Suppl 3):S37−S45.

Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Rabon-Stith K, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522−535.

Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. pdf icon[PDF – 190K] Prev Chronic Dis. 2006;3(2):A57.

Burwick N, Adams SV, Todd-Stenberg JA, Burrows NR, Pavkov ME, O’Hare AM. Association of monoclonal gammopathy with progression to ESKD among US Veteransexternal icon. Clin J Am Soc Nephrol. 2018;13(12):1810-1815.

Huang Y, Tilea A, Gillespie B, et al. Understanding trends in kidney function 1 year after kidney transplant in the United Statesexternal icon. J Am Soc Nephrol. 2017;28(8):2498–2510.

Wong SP, Hebert PL, Laundry RJ, et al. Decisions about renal replacement therapy in patients with advanced kidney disease in the US Department of Veterans Affairs, 2000–2011external icon. Clin J Am Soc Nephrol. 2016;11(10):1825–1833.

Hsu RK, McCulloch CE, Heung M, et al. Exploring potential reasons for the temporal trend in dialysis-requiring AKI in the United Statesexternal icon. Clin J Am Soc Nephrol. 2016;11(1):14-20.

Wong SP, Vig EK, Taylor JS, et al. Timing of initiation of maintenance dialysis: a qualitative analysis of the electronic medical records of a national cohort of patients from the Department of Veterans Affairsexternal icon. JAMA Intern Med. 2016 ;176(2):228-235.

O’Hare AM, Batten A, Burrows NR, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysisexternal icon. Am J Kidney Dis. 2012 Apr;59(4):513–522.

O’Hare AM, Hailpern SM, Pavkov ME, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetesexternal icon. Arch Intern Med. 2010;170(11):930−936.

Burrows NR, Vassalotti JA, Saydah SH, et al. Identifying high-risk individuals for chronic kidney disease: results of the CHERISH Community Demonstration Projectexternal icon. Am J Nephrol. 2018;48(6):447–455.

Saydah SH, Pavkov ME, Zhang C, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009–2010external icon. Clin Chem. 2013;59(4):1–9.

Vassalotti JA, Fox CH, Becker BN. Risk factors and screening for chronic kidney disease.external icon Adv Chronic Kidney Dis. 2010;17(3):237–245.

Collins AJ, Vassalotti JA, Wang C, et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.external icon Am J Kidney Dis. 2009;53(3 Suppl 3):S71–77.

Dharmarajan SH, Bragg-Gresham JL, Morgenstern H, et al.; Centers for Disease Control and Prevention CKD Surveillance System. State-level awareness of chronic kidney disease in the U.S.external icon Am J Prev Med. 2017;53(3):300-307.

Tuot DS, Plantinga LC, Hsu CY, et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. pdf icon[PDF – 201K]external icon Clin J Am Soc Nephrol. 2011;6(8):1838–1844.

Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. pdf icon[PDF – 226K]external icon Adv Chronic Kidney Dis. 2010;17(3):225–236.

Plantinga LC, Boulware LE, Coresh J, et al. Patient awareness of chronic kidney disease: trends and predictors. pdf icon[PDF – 986K]external icon Arch Intern Med. 2008;168(20):2268–2275.

Murphy D , McCulloch CE , Lin F , et al. Trends in prevalence of chronic kidney disease in the United Statesexternal icon. Annual of Intern Med. 2016;165(7):473-481.

Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiativepdf iconexternal icon. Am J Kidney Dis. 2015;65(3):403–411.

Shahinian VB, Hedgeman E, Gillespie BW, et al. Estimating prevalence of CKD stages 3–5 using health system dataexternal icon. Am J Kidney Dis. 2013;61(6):930–938.

Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetesexternal icon. Clin J Am Soc Nephrol. 2010;5(4):673−682.

Crews DC, Plantinga LC, Miller ER III, et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.external icon Hypertension. 2010;55(5):1102−1109.

Yarnoff BO, Hoerger TJ, Shrestha SS, et al; CRIC Study Investigators. Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC studyexternal icon. PLoS One. 2018 Oct 19;13(10):e0205530.

Bragg-Gresham J, Morgenstern H, McClellan W, et al; Centers for Disease Control and Prevention CKD Surveillance System. County-level air quality and the prevalence of diagnosed chronic kidney disease in the US Medicare populationexternal icon. PLoS One. 2018 Jul 31;13(7):e0200612.

Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration dataexternal icon. Am J Kidney Dis. 2016;67(5):742-752.

Banerjee T, Scherzer R, Powe NR, et al. Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veteransexternal icon. J Acquir Immune Defic Syndr. 2014;67(2):145-152.

Food and Diet

Banerjee T, Crews DC, Tuot DS, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertensionexternal icon. Kidney Int. 2019 Mar 4. [Epub ahead of print]

Banerjee T, Crews D, Wesson DE, et al. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end stage renal disease.external icon Am J Physiol Renal Physiol. 2019 Mar 25. [Epub ahead of print]

Crews DC, Banerjee T, Wesson DE, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Race/ethnicity, dietary acid load, and risk of end-stage renal disease among US adults with chronic kidney diseaseexternal icon. Am J Nephrol. 2018;47(3):174-181.

Banerjee T, Crews DC, Wesson DE, et al; CDC CKD Surveillance Team. Food insecurity, CKD, and subsequent ESRD in US adultsexternal icon. Am J Kidney Dis. 2017;70(1):38–47.

Banerjee T, Crews DC, Wesson DE, et al. High dietary acid load predicts ESRD among adults with CKDexternal icon. J Am Soc Nephrol. 2015;26(7):1693-1700.

Banerjee T, Crews DC, Wesson DE, et al. Dietary acid load and chronic kidney disease among adults in the United Statesexternal icon. BMC Nephrol. 2014;15:137.

Crews DC, Kuczmarski MF, Grubbs V, et al. Effect of food insecurity on chronic kidney disease in lower-income Americansexternal icon. Am J Nephrol. 2014;39(1):27–35.

Medicine and Supplements

Tuot DS, Lin F, Shlipak MG, et al. Potential impact of prescribing metformin according to eGFR rather than serum creatinineexternal icon. Diabetes Care. 2015;38(11):2059-2067.

Grubbs V, Plantinga LC, Tuot DS, et al. Americans’ use of dietary supplements that are potentially harmful in CKDpdf iconexternal icon. Am J Kidney Dis. 2013;61(5):739–747.

Plantinga L, Grubbs V, Sarkar U, et al. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. pdf icon[PDF – 333K]external icon Ann Fam Med. 2011;9(5):423–430.

Plantinga LC, Miller ER III, Stevens LA, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006.external icon Hypertension. 2009;54(1):47–56.

Carlos CA, McCulloch CE, Hsu CY, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Colon cancer screening among patients receiving dialysis in the United States: are we choosing wisely?external icon J Am Soc Nephrol. 2017;28(8):2521–2528.

Gillespie BW, Morgenstern H, Hedgeman E, et al. Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USAexternal icon. Clin Kidney J. 2015;8(6):772‒780.

Plantinga L, Lee K, Inker LA, et.al. Association of sleep-related problems with CKD in the United States, 2005–2008external icon. Am J Kidney Dis. 2011;58(4):554–564.

Grubbs V, Plantinga LC, Crews DC, et al. Vulnerable populations and the association between periodontal and chronic kidney disease. pdf icon[PDF – 212K]external icon Clin J Am Soc Nephrol. 2011;6(4):711–717.

Plantinga LC, Johansen K, Crews DC, et al. Association of CKD with disability in the United States. pdf icon[PDF – 597K]external icon Am J Kidney Dis. 2011;57(2):212–227.

Yarnoff BO, Hoerger TJ, Simpson SK, et al; Centers for Disease Control and Prevention CKD Initiative. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.external icon BMC Nephrol. 2017;18(1):85.

Yarnoff BO, Hoerger TJ, Simpson SA, et al. The cost-effectiveness of anemia treatment for persons with chronic kidney diseaseexternal icon. PLoS One. 2016;11(7):e0157323.

Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare populationexternal icon.J Am Soc Nephrol. 2013;24(9):1478–1483.

Hoerger TJ, Wittenborn J, Zhuo X, et al. Cost-effectiveness of screening for microalbuminuria among African Americansexternal icon. J Am Soc Nephrol. 2012;23(12):2035–2041.

Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. model construction, assumptions, and validation of health consequences.external icon Am J Kidney Dis. 2010;55(3):452–462.

Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.external icon Am J Kidney Dis. 2010;55(3):463–473.

Incidence of ESRD

Burrows NR, Hora I, Geiss LS, Gregg EW, Albright A. Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014. November 3, 2017 / 66(43);1165–1170.

Bullock A, Burrows NR, Narva AS, et al.
Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives — United States, 1996–2013. January 13, 2017 / 66(01);26–32.

Burrows NR, Hora I, Williams DE, Geiss LS. Trends in Incidence of End-Stage Renal Disease Among Persons With Diagnosed Diabetes — Puerto Rico, 1996–2010. March 7, 2014 / 63(09);186-189.

Burrows NR, Hora I, Cho P, Gerzoff RB, Geiss LS. Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons With Diagnosed Diabetes—United States and Puerto Rico, 1996–2007. October 29, 2010 / 59(42);1361-1366.

Burrows NR, Wang J, Geiss LS, Venkat Narayan KM, Engelgau MM. Incidence of End-Stage Renal Disease Among Persons with Diabetes—United States, 1990–2002. November 4, 2005 / 54(43);1097-1100.

Gilbertson D, Burrows NR, Wang J, Rolka D, Geiss LS, Williams DE. Racial Differences in Trends of End-Stage Renal Disease, by Primary Diagnosis—United States, 1994–2004. March 23, 2007 / 56(11);253-256.

Prevalence of CKD and ESRD

Saydah S, Eberhardt M, Burrows NR, Williams D, Geiss L, Dorsey R. Prevalence of Chronic Kidney Disease and Associated Risk Factors United States, 1999–2004. March 2, 2007 / 56(08);161-165.

Pirtle CJ, Schoolwerth AC, Giles WH, Brown DW, Mokdad AH, Ford ES. State-Specific Trends in Chronic Kidney Failure—United States, 1990–2001. October 8, 2004 / 53(39);918-920.

Hospitalization and Mortality

Pavkov ME, Harding JL, Burrows NR. Trends in Hospitalizations for Acute Kidney Injury — United States, 2000–2014. March 16, 2018 / 67(10);289–293.

Flowers NT, Croft JB. Hospitalization Discharge Diagnoses for Kidney Disease—United States, 1980–2005. March 28, 2008 / 57(12);309-312

Andrews A, El Reda DK, Radford G, Burrows NR, Ernst K. Kidney Disease Mortality—Michigan, 1989–2005. March 16, 2007 / 56(10);225-227.